glp-1 therapy in washington dc Patients Face New Barriers for Drugs IUPHAR review – Glucagon-like peptide-1

Abstract The most well-known type of focal epilepsy that is resistant to existing treatments is temporal lobe epilepsy (TLE), with seizure foci in various structures including temporal lobe, hippocampus, amygdala, entorhinal cortex, and subcortex

To develop novel protease inhibitors with high activity and selectivity, grassypeptolide 59 was synthesized by Jason C

Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human

Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons

Glutone Face Wash : A skin brightening face wash for daily radiance